|
|
|
|
|||||
|
|
|
Total Revenue of $12.4 Million
Direct Operating Margin of 58%, a 7% Improvement over Prior Year Quarter
LOS ANGELES, Nov. 14, 2025 /PRNewswire/ -- Cineverse Corp. ("Cineverse" or the "Company") (NASDAQ: CNVS), a next-generation entertainment studio, today announced its financial results for its second quarter ended September 30, 2025 ("Q2 FY 2026"):
Total Revenue declined 3% year-over-year, primarily reflecting differences in the timing of revenue recognition for certain content licensing agreements. In the prior-year quarter, the Company recorded $1.6 million from a Dog Whisperer licensing agreement, while this quarter includes a recently signed $1.1 million licensing deal for The Toxic Avenger Unrated that will be recognized in future periods. Excluding these timing effects, performance across the Company's core business lines continued to show solid underlying growth.
Direct Operating Margin improved by 7% compared to the prior-year quarter. Net Loss and Adjusted EBITDA reflect increased SG&A driven by approximately $2.3 million of marketing costs tied to the launch of The Toxic Avenger Unrated and ongoing investments to support the expansion of Cineverse's theatrical slate and the build-out of its Technology group's business development, product, and sales capabilities. The Toxic Avenger Unrated is performing strongly in ancillary markets and is projected to generate an IRR of over 40%.
Subsequent to quarter end, Cineverse announced another key addition to its theatrical slate. In late 2026, the Company will reissue the 20th anniversary edition of Pan's Labyrinth, the acclaimed Guillermo del Toro film that won three Academy Awards and over 100 international honors. Cineverse will return to the Cannes Film Festival next May for a special anniversary presentation to kick off the marketing campaign for a Fall 2026 wide release.
Q2 FY 2026 Highlights (all comparisons are to the prior year fiscal quarter ended September 30, 2024, or Q2 FY 2025):
Total quarterly revenue was $12.4 million versus $12.7 million in the prior-year quarter, a 3% decrease, driven by gains in streaming and digital distribution, as well as theatrical sales.
SG&A expenses increase by $5.0 million, or 79%, to $11.4 million, reflecting increased compensation, marketing and professional services costs, as a result of ramping up for an increased theatrical slate for the remainder of the year as well as start-up costs associated with our MicroCo venture. Included in SG&A during the quarter was approximately $2.3 million of marketing costs associated with the release of The Toxic Avenger Unrated.
Net loss attributable to common stockholders was $(5.7) million, or $(0.31) per basic and diluted share, compared to a net loss of $1.4 million, or $(0.09) per share, in the prior-year quarter. Adjusted EBITDA was $(3.7) million, compared to $0.5 million last year.
Financial Condition Overview:
Operational Developments During the Quarter:
Operational Developments Subsequent to Quarter-End:
Management Commentary:
Chris McGurk, Cineverse Chairman and CEO, stated: "Our year-over-year comparison reflects differences in the timing of revenue recognition related to content licensing transactions. In the prior-year period, we recognized $1.6 million from a distribution agreement for our Dog Whisperer streaming channel. This year, we closed a significant licensing agreement for The Toxic Avenger Unrated during the quarter, totaling approximately $1.1 million, for which revenue will be recognized in future periods.
"Excluding the effect of these timing differences, our results reflect solid performance across our core business lines. Operating margin expanded to 58%, an increase of 7 percentage points over the prior-year quarter. Adjusted EBITDA and net income were affected by planned investments in our wide-release film business and our Technology group, and we expect these investments to contribute to future growth. We also continue to benefit from cost efficiencies through our Cineverse Services India operations.
"The Toxic Avenger Unrated, released on August 29th, did not perform as well as we had hoped at the box office. However, our campaign has helped generate significant returns for the film in the ancillary markets, particularly in VOD, physical goods and licensing. With an all-in acquisition and marketing release investment of less than $5 million, we expect the film will be profitable, with an IRR conservatively projected at over 40%. We own the domestic distribution rights for the film in perpetuity, and believe it is a great addition to our library. This performance also underscores the low risk/high potential return profile of our theatrical film portfolio strategy.
"Prior to quarter end, we also announced that we will be releasing the 20th anniversary edition of Pan's Labyrinth, the Academy Award winning masterpiece from acclaimed director Guillermo del Toro. Next May, to kick off the campaign for a Fall 2026 release, we plan to take the film back to the Cannes Film Festival, where it received the longest standing ovation in the history of the Festival upon its premiere in 2006. With a multi-year distribution window for this extraordinary film, we also believe it will be another strong addition to our library of rights.
"And our content library of over 66,000 titles recently received an updated independent valuation of $45 million, significantly above the $3.2 million book value recorded at quarter end.
"We also continue to rapidly build out our pipeline of Matchpoint™ technology partnerships with major studio players and recently closed four of those deals. We continue to move aggressively forward with MicroCo, our microdrama joint venture with Banyan Ventures. Expect additional significant announcements of our progress in both those businesses soon."
Erick Opeka, Cineverse President and Chief Strategy Officer, stated: "This quarter, we continued to execute on our strategy to grow Cineverse as both a technology and entertainment leader while maintaining a disciplined focus on profitability. Our Matchpoint™ platform achieved significant momentum, adding over 20 new customers in the last 100 days and entering a pilot program with a major Hollywood studio. We are also in active discussions with many others across the industry, who are seeking platforms that can accelerate integration, improve automation, and meaningfully reduce operating costs. This growing adoption validates our technology leadership and positions us to scale efficiently. We are also evaluating strategic partnerships that could further accelerate expansion, while maintaining our focus on financial discipline and operating leverage.
"Our microdrama platform business, preliminarily named MicroCo, continues to advance ahead of plan. We have assembled an exceptional leadership team with experience, having managed more than 50 million streaming subscribers, producing over 30 long-running television series, and overseeing billions of dollars in content revenue. Development is underway on our first slate of MicroCo projects and shows for launch next year, supported by a significant investment commitment from a leading venture capital firm. We believe MicroCo can become a meaningful contributor to future growth, and we are managing its development with the same emphasis on cost control and return on investment that guides our core operations.
"At the same time, we are maintaining best-in-class gross margins in our streaming and distribution business by rationalizing SG&A through targeted efficiencies, and leveraging our India-based technology and operations teams to lower costs and improve productivity. These actions, combined with a disciplined content and release strategy, support continued margin improvement and stronger cash-flow performance.
"Our focus remains clear: to build a scalable, high-margin digital entertainment company that combines innovative technology with efficient content monetization. We are encouraged by the growing interest from leading Hollywood partners in our release model and technology platforms, and we remain committed to disciplined execution and long-term value creation for our shareholders."
Conference Call
Cineverse will host a conference call at 4:30 p.m. EST/1:30 p.m. PST (Friday, November 14, 2025), during which management will discuss the results of its fiscal second quarter ended September 30, 2025.
Call details are as follows:
About Cineverse
Cineverse (Nasdaq: CNVS) is a next-generation entertainment studio that empowers creators and entertains fans with a wide breadth of content through the power of technology. It has developed a new blueprint for delivering entertainment experiences to passionate audiences, and results for its partners with unprecedented efficiency, and distributes more than 66,000 premium films, series, and podcasts. Cineverse connects fans with bold, authentic, independent stories. Properties include the highest-grossing unrated film in U.S. history; dozens of streaming fandom channels; a premier podcast network; top horror destination Bloody Disgusting; and more. Powering visionary storytelling with cutting-edge innovation, Cineverse's proprietary streaming tools and AI technology drive revenue and reach to redefine the next era of entertainment. For more information, visit home.cineverse.com.
Safe Harbor Statement
Investors and readers are cautioned that certain statements contained in this document, as well as some statements in periodic press releases and some oral statements of Cineverse officials during presentations about Cineverse, along with Cineverse's filings with the Securities and Exchange Commission, including Cineverse's registration statements, quarterly reports on Form 10-Q and annual report on Form 10-K, are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act''). Forward-looking statements include statements that are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "expects," "anticipates,'' "intends,'' "plans,'' "could," "might," "believes,'' "seeks," "estimates'' or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings, or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by Cineverse's management, are also forward-looking statements as defined by the Act. Forward-looking statements are based on current expectations and projections about future events and are subject to various risks, uncertainties, and assumptions about Cineverse, its technology, economic and market factors, and the industries in which Cineverse does business, among other things. These statements are not guarantees of future performance, and Cineverse undertakes no specific obligation or intention to update these statements after the date of this release.
For additional information, please contact:
Julie Milstead
424-281-5411
[email protected]
|
CINEVERSE CORP. |
|
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
|
|||||||
|
(in thousands) |
|
|||||||
|
|
|
As of |
|
|||||
|
|
|
September 30, |
|
|
March 31, |
|
||
|
|
|
(Unaudited) |
|
|
|
|
||
|
ASSETS |
|
|
|
|
|
|
||
|
Current Assets |
|
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
2,336 |
|
|
$ |
13,941 |
|
|
Accounts receivable, net |
|
|
13,749 |
|
|
|
15,752 |
|
|
Content advances |
|
|
5,384 |
|
|
|
6,736 |
|
|
Other current assets |
|
|
1,789 |
|
|
|
1,652 |
|
|
Total Current Assets |
|
|
23,258 |
|
|
|
38,081 |
|
|
Property and equipment, net |
|
|
3,070 |
|
|
|
2,876 |
|
|
Intangible assets, net |
|
|
18,405 |
|
|
|
18,168 |
|
|
Goodwill |
|
|
6,799 |
|
|
|
6,799 |
|
|
Content advances, net of current portion |
|
|
7,941 |
|
|
|
4,053 |
|
|
Other long-term assets |
|
|
2,474 |
|
|
|
2,539 |
|
|
Total Assets |
|
$ |
61,947 |
|
|
$ |
72,516 |
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
||
|
Current Liabilities |
|
|
|
|
|
|
||
|
Accounts payable and accrued expenses |
|
$ |
17,537 |
|
|
$ |
31,109 |
|
|
Line of credit |
|
|
6,645 |
|
|
|
- |
|
|
Current portion of earnout and deferred consideration on purchase of business |
|
|
- |
|
|
|
2,956 |
|
|
Operating lease liabilities |
|
|
293 |
|
|
|
187 |
|
|
Current portion of deferred revenue |
|
|
49 |
|
|
|
183 |
|
|
Total Current Liabilities |
|
|
24,524 |
|
|
|
34,435 |
|
|
Operating lease liabilities, net of current portion |
|
|
260 |
|
|
|
275 |
|
|
Other long-term liabilities |
|
|
- |
|
|
|
14 |
|
|
Total Liabilities |
|
|
24,784 |
|
|
|
34,724 |
|
|
Stockholders' Equity |
|
|
|
|
|
|
||
|
Preferred stock |
|
|
3,559 |
|
|
|
3,559 |
|
|
Common Stock |
|
|
197 |
|
|
|
194 |
|
|
Additional paid-in capital |
|
|
557,994 |
|
|
|
548,405 |
|
|
Treasury stock, at cost |
|
|
(13,158) |
|
|
|
(12,193) |
|
|
Accumulated deficit |
|
|
(510,235) |
|
|
|
(500,908) |
|
|
Accumulated other comprehensive loss |
|
|
(322) |
|
|
|
(305) |
|
|
Total stockholders' equity of Cineverse Corp. |
|
|
38,035 |
|
|
|
38,752 |
|
|
Deficit attributable to noncontrolling interest |
|
|
(872) |
|
|
|
(960) |
|
|
Total equity |
|
|
37,163 |
|
|
|
37,792 |
|
|
Total Liabilities and Equity |
|
$ |
61,947 |
|
|
$ |
72,516 |
|
|
CINEVERSE CORP. |
|
|||||||||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|
|||||||||||||||
|
(In thousands, except for per share data) |
|
|||||||||||||||
|
(Unaudited) |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
Revenues |
|
$ |
12,357 |
|
|
$ |
12,739 |
|
|
$ |
23,476 |
|
|
$ |
21,866 |
|
|
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Direct operating |
|
|
5,214 |
|
|
|
6,262 |
|
|
|
10,021 |
|
|
|
10,741 |
|
|
Selling, general and administrative |
|
|
11,407 |
|
|
|
6,364 |
|
|
|
20,359 |
|
|
|
12,927 |
|
|
Depreciation and amortization |
|
|
1,146 |
|
|
|
974 |
|
|
|
2,208 |
|
|
|
1,837 |
|
|
Total operating expenses |
|
|
17,767 |
|
|
|
13,600 |
|
|
|
32,588 |
|
|
|
25,505 |
|
|
Operating loss |
|
|
(5,410) |
|
|
|
(861) |
|
|
|
(9,112) |
|
|
|
(3,639) |
|
|
Interest (expense) income |
|
|
(147) |
|
|
|
(337) |
|
|
|
131 |
|
|
|
(768) |
|
|
Other (expense) income, net |
|
|
32 |
|
|
|
1 |
|
|
|
(46) |
|
|
|
167 |
|
|
Net loss before income taxes |
|
|
(5,525) |
|
|
|
(1,197) |
|
|
|
(9,027) |
|
|
|
(4,240) |
|
|
Income tax expense |
|
|
(20) |
|
|
|
(6) |
|
|
|
(34) |
|
|
|
(13) |
|
|
Net loss |
|
|
(5,545) |
|
|
|
(1,203) |
|
|
|
(9,061) |
|
|
|
(4,253) |
|
|
Net income attributable to noncontrolling interest |
|
|
(44) |
|
|
|
(84) |
|
|
|
(88) |
|
|
|
(106) |
|
|
Net loss attributable to controlling interests |
|
|
(5,589) |
|
|
|
(1,287) |
|
|
|
(9,149) |
|
|
|
(4,359) |
|
|
Preferred stock dividends |
|
|
(89) |
|
|
|
(89) |
|
|
|
(178) |
|
|
|
(177) |
|
|
Net loss attributable to common stock holders |
|
$ |
(5,678) |
|
|
$ |
(1,376) |
|
|
$ |
(9,327) |
|
|
$ |
(4,536) |
|
|
Net loss per share attributable to common stock holders: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic and diluted |
|
$ |
(0.31) |
|
|
$ |
(0.09) |
|
|
$ |
(0.53) |
|
|
$ |
(0.29) |
|
|
Weighted average shares of common stock outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic and diluted |
|
|
18,447 |
|
|
|
15,721 |
|
|
|
17,720 |
|
|
|
15,711 |
|
Adjusted EBITDA
We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation expense, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment and certain other items.
Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business, because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including our stockholders, as a valuable financial metric.
We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net income (loss) from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes, and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.
We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net income (loss) from operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to net income (loss) from operations as an indicator of performance, or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.
Following is the reconciliation of our consolidated net income (loss) to Adjusted EBITDA (in thousands):
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
Net loss |
|
$ |
(5,545) |
|
|
$ |
(1,203) |
|
|
$ |
(9,061) |
|
|
$ |
(4,253) |
|
|
Add Back: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Income tax expense |
|
|
20 |
|
|
|
6 |
|
|
|
34 |
|
|
|
13 |
|
|
Depreciation and amortization |
|
|
1,275 |
|
|
|
974 |
|
|
|
2,422 |
|
|
|
1,837 |
|
|
Interest expense (income) |
|
|
147 |
|
|
|
337 |
|
|
|
(131) |
|
|
|
768 |
|
|
Stock-based compensation |
|
|
494 |
|
|
|
503 |
|
|
|
912 |
|
|
|
973 |
|
|
Other (income) expense, net |
|
|
(32) |
|
|
|
(1) |
|
|
|
46 |
|
|
|
(167) |
|
|
Net income attributable to noncontrolling interest |
|
|
(44) |
|
|
|
(84) |
|
|
|
(88) |
|
|
|
(106) |
|
|
Transition-related costs |
|
|
— |
|
|
|
— |
|
|
|
47 |
|
|
|
27 |
|
|
Adjusted EBITDA |
|
$ |
(3,685) |
|
|
$ |
532 |
|
|
$ |
(5,819) |
|
|
$ |
(908) |
|
SOURCE Cineverse Corp.
| 9 hours | |
| Nov-15 | |
| Nov-14 | |
| Nov-13 | |
| Nov-07 | |
| Nov-05 | |
| Nov-03 | |
| Oct-28 | |
| Oct-25 | |
| Oct-10 | |
| Oct-06 | |
| Sep-26 | |
| Sep-16 | |
| Sep-12 | |
| Sep-10 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite